Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration

Published:2021-04-01 Issue:4 Volume:139 Page:441
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Enríquez Ana Bety¹,Baumal Caroline R.¹,Crane Ashley M.²,Witkin Andre J.¹,Lally David R.³⁴,Liang Michelle C.¹,Enríquez José Ramón⁵,Eichenbaum David A.²

Affiliation:

1. New England Eye Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts

2. Retina-Vitreous Associates of Florida, Tampa

3. New England Retina Consultants, Springfield, Massachusetts

4. Department of Surgery, University of Massachusetts Medical School–Baystate, Springfield

5. Harvard University, Cambridge, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2776731/jamaophthalmology_enrquez_2021_oi_200120_1618442128.68621.pdf

Reference45 articles.

1. Brolucizumab: first approval.;Markham;Drugs,2019

2. Systemic anibizumab.;Avery;Retina,2017

3. Affinity and potency of RTH258 (ESBA1008), a novel inhibitor of vascular endothelial growth factor A for the treatment of retinal disorders.;Tietz;Invest Ophthalmol Vis Sci,2015

4. Brolucizumab: evolution through preclinical and clinical studies and the implications for the management of neovascular age-related macular degeneration.;Nguyen;Ophthalmology,2020

5. Brolucizimab—leading an era of structural revolution for long-term VEGF suppression.;Sharma;Eye (Lond),2020

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1;Journal of VitreoRetinal Diseases;2024-08-22

2. Brolucizumab-associated intraocular inflammation in Indian patients by VRSI study group;Indian Journal of Ophthalmology;2024-07-29

3. Treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor drugs: progress from mechanisms to clinical applications;Frontiers in Medicine;2024-07-19

4. Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degeneration;PLOS ONE;2024-04-18

5. Brolucizumab effectiveness in pigment epithelium detachment due to exudative AMD in naïve treatment or non-responder patients;European Journal of Ophthalmology;2024-03-11